- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06131970
The Effectiveness of Continuous Ketamine Infusion (KONTINUE) (KONTINUE)
November 13, 2023 updated by: Centre Hospitalier Princesse Grace
Effectiveness of Continuous Ketamine Infusion Associated With Magnesium Sulfate for Management of Patient With Chronic Pain : a Prospective Observational Study
There are different treatment for chronic pain.
One possible treatment is intravenous infusions of ketamine.
Study Overview
Status
Recruiting
Conditions
Detailed Description
Ketamine continuous intravenous infusion for 4 days in Hospital with 0.5 mg/kg/day associated with Magnesium Sulfate 1000mg/day.
Evaluation schedules will be performed at day 15,30 and 60.
Study Type
Observational
Enrollment (Estimated)
80
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jean-Marie AMODEO, MD
- Phone Number: 00 377 97 98 97 02
- Email: jmamodeo@chpg.mc
Study Locations
-
-
-
Monaco, Monaco, 98000
- Recruiting
- Centre Hospitalier Princesse Grace
-
Principal Investigator:
- Jean-Marie AMODEO, MD
-
Contact:
- Mélody LABIT
- Email: recherche.clinique@chpg.mc
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
Patients with chronic pain treated with ketamine infusion
Description
Inclusion Criteria:
- Pain lasting for more than six months without contraindication to treatment
Exclusion Criteria:
- Inability to give consent
- Severe psychiatric disorder
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Long-term effectiveness
Time Frame: 1 month
|
Improvement of the numerical scale - score 0 to 10 - 10 is the worst
|
1 month
|
Long-term effectiveness
Time Frame: 1 month
|
Clinical Global Impression of Change (CGI-C) - score 1 to 7 - 7 is the worst
|
1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain relief
Time Frame: 15, 30, 60 days
|
Neuropathic Pain Symptom Inventory (NPSI) - score 0 to 10 - 10 is the worst
|
15, 30, 60 days
|
Variation of quality of life
Time Frame: 15, 30, 60 days
|
Short Form 12 health survey
|
15, 30, 60 days
|
Variation of quality of life
Time Frame: 15, 30, 60 days
|
Hospital Anxiety and Depression scale - score 0 to 21 - 21 is the worst
|
15, 30, 60 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 22, 2022
Primary Completion (Estimated)
December 24, 2023
Study Completion (Estimated)
February 25, 2024
Study Registration Dates
First Submitted
November 7, 2023
First Submitted That Met QC Criteria
November 13, 2023
First Posted (Actual)
November 15, 2023
Study Record Updates
Last Update Posted (Actual)
November 15, 2023
Last Update Submitted That Met QC Criteria
November 13, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 21-12
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Pain
-
Pain ConcernThe Thistle Foundation; Health and Social Care Alliance Scotland (the ALLIANCE) and other collaboratorsCompletedChronic Pain | Chronic Pain Syndrome | Chronic Pain, Widespread | Chronic Pain Due to Trauma | Chronic Pain Due to Malignancy (Finding) | Chronic Pain Due to Injury | Chronic Pain Post-Procedural | Chronic Pain HipUnited Kingdom
-
Consorci Sanitari de l'Alt Penedès i GarrafRecruitingChronic Post Operative Pain | Chronic Post-surgical Pain | Chronic Knee PainSpain
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
University of Alabama, TuscaloosaPatient-Centered Outcomes Research Institute; East Carolina University; Whatley...CompletedPain | Chronic Pain | Chronic Pain Syndrome | Widespread Chronic Pain | Chronic Pain Due to InjuryUnited States
-
University of UtahRecruitingChronic Pain | Chronic Pain Syndrome | Widespread Chronic PainUnited States
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Thoracotomy | Postoperative Pain, Acute | Postoperative Pain, ChronicTurkey
-
Evolve Restorative CenterFlowonix Medical; Celéri Health, Inc.; Advanced Infusion SolutionsCompletedPain, Chronic | Pain, Intractable | Chronic Nonmalignant PainUnited States
-
Assiut UniversityNot yet recruiting
-
Vastra Gotaland RegionActive, not recruitingPain, Chronic | Widespread Chronic PainSweden
-
Istanbul UniversityCompletedLow Back Pain, Mechanical, Biofeedback, Pain, Chronic